AWARD
R -- RECOVERY - ADOPT Common Infrastructure Support under Operation and Support of the Cancer Therapy Evaluation Program's Cancer Trials Support Unit (CTSU)
- Notice Date
- 9/28/2009
- Notice Type
- Award Notice
- NAICS
- 541690
— Other Scientific and Technical Consulting Services
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 6120 Executive Blvd., EPS Suite 600, Rockville, Maryland, 20852
- ZIP Code
- 20852
- Point of Contact
- John R. Manouelian, Phone: (301) 435-3813, Richard L Hartmann, Phone: (301) 496-8620
- E-Mail Address
-
manouelj@mail.nih.gov, hartmari@mail.nih.gov
(manouelj@mail.nih.gov, hartmari@mail.nih.gov)
- Small Business Set-Aside
- N/A
- Award Number
- HHSN261200622012C-011
- Award Date
- 9/30/2009
- Awardee
- Westat, Inc. (DUNS 049508120), 1650 Research Blvd., 1650 Research Blvd., Maryland 20850-3195, United States
- Award Amount
- $2,240,090
- Line Number
- Modification_11
- Description
- This action modifies an existing contract to provide funding for ADOPT common infrastructure support. This contract provides the type of clinical trials support that will be necessary to incorporate new technologies for electronic data capture and verification. The Cancer Trials Support Unit (CTSU) is a service of the National Cancer Institute (NCI) that provides clinicians across the United States access to cancer treatment trials. The project is funded and directed by the NCI Cancer Therapy Evaluation Program (CTEP) and operated by Westat, Inc. The objectives of the CTSU include: providing a wide choice of clinical trial options to the largest possible number of investigators; involving a larger number of treating institutions in the clinical trials process; increasing enrollment to cancer clinical trials; streamlining or eliminating redundant processes and procedures; and providing data management services for clinical trials. Rationale for using other than a fixed price: Uncertainties involved in contract performance do not permit costs to be estimated with sufficient accuracy to use any type of fixed price contract. As such, a cost reimbursement type action is appropriate. The primary purpose of the project is to standardize and create common infrastructure to improve the efficiency and effectiveness of the CTEP multi-center clinical trial networks, while simultaneously providing an opportunity to reduce clinical trial costs.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/RCB/Awards/HHSN261200622012C-011.html)
- Record
- SN01972658-W 20090930/090928235635-eff60d9a374524703eaa408796ae577a (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |